RG

Redmile Group Portfolio holdings

AUM $940M
1-Year Est. Return 75.78%
This Quarter Est. Return
1 Year Est. Return
+75.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.3B
AUM Growth
-$140M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
80
New
Increased
Reduced
Closed

Top Buys

1 +$40.1M
2 +$39M
3 +$32.6M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$31.9M
5
BMY icon
Bristol-Myers Squibb
BMY
+$31.2M

Top Sells

1 +$38.9M
2 +$37M
3 +$25.3M
4
AKRO icon
Akero Therapeutics
AKRO
+$22.5M
5
FOLD icon
Amicus Therapeutics
FOLD
+$21.1M

Sector Composition

1 Healthcare 98.78%
2 Industrials 1.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
1
$203M 8.83%
18,346,861
-1,902,928
2
$153M 6.65%
1,913,280
+16,635
3
$102M 4.44%
4,205,206
-296,905
4
$86.2M 3.74%
5,582,105
+1,988,788
5
$78.2M 3.39%
2,044,389
-588,523
6
$77.8M 3.38%
2,925,648
-952,951
7
$73.9M 3.2%
12,957,222
8
$71.4M 3.1%
2,410,769
-263,068
9
$67.6M 2.93%
1,879,739
-97,712
10
$67.3M 2.92%
3,811,988
-1,019,721
11
$54.9M 2.38%
6,067,918
-108,000
12
$52.4M 2.27%
187,992
-33,817
13
$51.7M 2.24%
1,186,418
+80,009
14
$49.4M 2.14%
1,612,094
-158,493
15
$49M 2.13%
335,159
+16,214
16
$48.6M 2.11%
130,540
-17,977
17
$47.5M 2.06%
1,325,832
-1,034,582
18
$45.8M 1.99%
3,334,355
19
$41.1M 1.78%
1,061,295
-359,322
20
$40.1M 1.74%
+610,304
21
$39M 1.69%
+336,048
22
$39M 1.69%
136,464
+30,584
23
$34.5M 1.5%
4,145,396
+3,502,966
24
$32.6M 1.41%
+335,170
25
$31.9M 1.39%
+231,595